Clinical trial
Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery
NCT06320041 is registered in ClinicalTrials.gov with The Fourth Affiliated Hospital of Zhejiang University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery
- Lead sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 162 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.